Eloxx Pharmaceuticals, Inc. (ELOX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 10, 2025, 8:00 PM EDT
Eloxx Pharmaceuticals Market Cap
Eloxx Pharmaceuticals has a market cap or net worth of $3.00 as of August 12, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
3.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 21, 2017, Eloxx Pharmaceuticals's market cap has decreased from 23.05M to 3.00, a decrease of -100.00%. That is a compound annual growth rate of -87.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 3.00 | - |
| Dec 31, 2024 | 3.00 | -100.00% |
| Dec 29, 2023 | 3.77M | -4.33% |
| Dec 30, 2022 | 3.94M | -93.53% |
| Dec 31, 2021 | 60.91M | -61.88% |
| Dec 31, 2020 | 159.81M | -45.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 625.65M |
| Glass House Brands | 497.52M |
| Northwest Biotherapeutics | 366.75M |
| American Oncology Network | 353.52M |
| CytoDyn | 322.85M |